Mucosomal allergen-specific immunotherapy with initial dosing after start of pollen season
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 2, 2016
Grant Date -
Jun 16, 2011
app pub date -
Apr 8, 2009
filing date -
Apr 11, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to mucosal allergen-specific immunotherapy with a seasonal allergen, wherein the therapy is initiated after start of the pollen season of the seasonal allergen. Preferably, the seasonal allergen is provided in solid dosage form and is administered daily. Furthermore, advantageously, the same dose may be used throughout the treatment period since up-dosing is not required.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully